Correction of defective host response to Mycobacterium bovis BCG infection in TNF-deficient mice by bone marrow transplantation

Laboratory Investigation

Volumn 80, Issue 6, 2000, Pages 901-914

  Jacobs, Muazzam ^b   Marino, Mike W ^a   Brown, Najmeeyah ^b   Abel, Brian ^b   Bekker, Linda Gail ^b   Quesniaux, Valerie J F ^b   Fick, Lizette ^b   Ryffel, Bernhard ^b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; CD11B ANTIGEN; CHEMOKINE; GLYCOPROTEIN P 15095; INTERCELLULAR ADHESION MOLECULE 1; MACROPHAGE INFLAMMATORY PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW TRANSPLANTATION; CELL ACTIVATION; CONTROLLED STUDY; FEMALE; GRANULOMA; HOST RESISTANCE; IMMUNE RESPONSE; LUNG BURDEN; LUNG LAVAGE; MACROPHAGE; MONONUCLEAR CELL; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033933238     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780094     Document Type: Article

References (39)

1. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le DF, Drysdale P, Jouanguy E, Doffinger R, Bernaudin F, Jeppsson O, Gollob JA, Meinl E, Segal AW, Fischer A, Kumararatne D, and Casanova JL (1998). Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280:1432-1435.
2. Banks TA, Rouse BT, Kerley MK, Blair PJ, Godfrey VL, Kuklin NK, Bouley DM, Thomas J, Kanangat S, and Mucenski ML (1995). Lymphotoxin-a deficient mice. J Immunol 155:1685-1693.
3. Barka T and Anderson PJ (1962). Histochemical methods for acid phosphatase using hexazonium pararosanilin as coupler. J Histochem Cytochem 10:741-748.
4. Bean AG, Roach DR, Briscoe H, France MP, Kroner H, Sedgwick JD, and Britton WJ (1999). Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for lymphotoxin. J Immunol 162:3504-3511.
5. Beutler B, Tkacenko V, Milsark I, Krochin N, and Cerami A (1986). Effect of gamma interferon on cachectin expression by mononuclear phagocytes. J Exp Med 164:1791-1796.
6. Bloom BR (1994). Tuberculosis. In: Bloom BR, editor. Tuberculosis: Pathogenesis, protection and control. Washington, DC: ASM Press, p. 389-503.
7. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RVJ, Broxmeyer HE, and Charo IF (1997). Impaired monocyte migration and reduced type 1 Th1 cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100: 2552-2561.
8. Chan J, Xing Y, Magliozzo RS, and Bloom BR (1992). Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 175:1111-1116.
9. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, and Orme IM (1993). Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178:2243-2247.
10. Cooper AM, Magram J, Ferrante J, and Orme IM (1997). Interleukin 12 is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 186:39-45.
11. Cooper AM, Roberts AD, Rhoades ER, Callahan JE, Getzy DM, and Orme IM (1995). The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. J Immunol 84:423-432.
12. Coxon A, Rieu P, Barkalow FJ, Askari S, Sharpe AH, von Andrian UH, Arnaout MA, and Mayadas TN (1996). A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: A homeostatic mechanism in inflammation. Immunity 5:653-666.
13. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, and Stewart TA (1993). Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259: 1739-1742.
14. de Jong R, Altare F, Haagen IA, Elferink DG, Boer T, van Breda Vriesman PJ, Kabel PJ, Draaisma JM, van Dissel JT, Kroon FP, Casanova JL, and Ottenhoff TH (1998). Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280:1435-1438.
15. De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S, Smith SC, Carlson R, Shornick LP, Strauss-Schoenberger J, Russel JH, Karr R, and Chaplin DD (1994). Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703-707.
16. Eugster HP, Muller M, Karrer U, Car BD, Schnyder B, Eng VM, Woerly G, Le Hir M, Di Padova F, Aguet M, Zinkernagel R, Bluethmann H, and Ryffel B (1996). Multiple immune abnormalities in tumor necrosis factor and lymphotoxina double-deficient mice. Int Immunol 8:23-36.
17. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, and Bloom BR (1993). An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178:2249-2254.
18. Flynn JL, Goldstein MM, Chan J, Triebold KJ, and Bloom BR (1995). Tumor necrosis factor-alpha is required in the protective immune response against mycobacterium tuberculosis in mice. Immunity 2:561-572.
19. Flynn JL, Scanga CL, Tanaka KE, and Chan J (1998). Effects of aminoguanidine on latent murine tuberculosis. J Immunol 160:1796-11803.
20. Gordon S, Lawson L, Rabinowitz S, Crocker PR, Morris L, and Perry VH (1992). Antigen markers of macrophage differentiation in murine tissues. Curr Topics Microbol Immunol 181:1-37.
21. Johnson CM, Cooper AM, Frank AA, and Orme IM (1998). Adequate expression of protective immunity in the absence of granuloma formation in Mycobacterium tuberculosis-infected mice with a disruption in the intracellular adhesion molecule-1 gene. Infect and Immun 66:1666-1670.
22. Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, Newport M, Levin M, Blanche S, Seboun E, Fischer A, and Casanova JL (1996). Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med 335:1956-1961.
23. Jouanguy E, Lamhamedi CS, Altare F, Fondaneche MC, Tuerlinckx D, Blanche S, Emile JF, Gaillard JL, Schreiber R, Levin M, Fischer A, Hivroz C, and Casanova JL (1997). Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J Clin Invest 100:2658-2664.
24. Kamijo R, Le J, Shapiro D, Havell EA, Huang S, Aguet M, Bosland M, and Vilcek J (1993a). Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J Exp Med 178: 1435-1440.
25. Kamijo R, Shapiro D, Le J, Huang S, Aguet M, and Vilcek J (1993b). Generation of nitric oxide and induction of MHC class II antigen in macrophages from mice lacking the IFN-gamma receptor. Proc Natl Acad Sci USA 90:6626-6632.
26. Kindler V, Sappino A-P, Grau GE, Piguet P-F, and Vassalli P (1989). The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740.
27. Kurihara T, Warr G, Loy J, and Bravo R (1997). Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 186:1757-1762.
28. Lin Y, Zhang M Barnes PF (1998). Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium Tuberculosis. Infect Immun 66:1121-1126.
29. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, North R, Gerard C, and Rollins BJ (1998). Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187: 601-608.
30. Lucas R, Tacchini-Cottier F, Guler R, Vesin D, Jemelin S, Olleros ML, Marchai G, Browning JL, Vassalli P, and Garcia I (1999). A role for lymphotoxin beta receptor in host defense against Mycobacterium bovis BCG infection. Eur J Immunol 29:4002-4010.
31. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, and Nathan CF (1997). Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 94:5243-5248.
32. Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, and Old LJ (1997). Characterisation of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 94:8093-8098.
33. Muller M, Eugster HP, Le Hir M, Shakhov A, Di Padova F, Maurer C, Quesniaux VFJ, and Ryffel B (1996). Correction and transfer of immunodeficiency due to TNF-LTa deletion by bone marrow transplantation. Mol Medicine 2:247-255.
34. Rhoades ER, Cooper AM, and Orme IA (1995). Chemokine response in mice infected with Mycobacterium tuberculosis. Infect and Immun 63:3871-3877.
35. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M, and Bluethmann H (1993). Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802.
36. Senaldi G, Yin S, Shaklee CL, Piguet P-F, Mak TW, and Ulich TR (1996). Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor 1 (TNF-RI) knockout mice and by treatment with soluble TNF-RI. J Immunol 157:5022-5026.
37. Smith D, Hänsch H, Bancroft G, and Ehlers S (1997). T-cell-independent granuloma formation in response to Mycobacterium avium: Role of tumour necrosis factor-alpha and interferon-gamma. Immunology 92:413-421.
38. Yassin RJ and Hamblin AS (1994). Altered expression of CD11/CD18 on the peripheral blood phagocytes of patients with tuberculosis. Clin Exp Immunol 97:120-125.
39. Zhou Y, Kurihara T, Ryseck R-P, Yang Y, Ryan C, Loy J, Warr G, and Bravo R (1998). Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 core-ceptor. J Immunol 160:4018-4025.